Laurus Labs, based in Hyderabad (India), is a leading developer and manufacturer of generic active pharmaceutical ingredients (“API”), with a focus on products where it has cost leadership led by innovation in process chemistry or manufacturing efficiencies. Since the start of commercial operations in 2008, Laurus Labs has built a leadership position in antiretroviral APIs. Over time, it has expanded its portfolio to include oncology and other select APIs where it has a cost advantage. The company has also successfully forward integrated into finished dosage formulations.
Warburg Pincus is a leading global private equity firm focused on thesis-driven growth investing at scale. With more than $58 billion in assets under management, our active portfolio of more than 190 companies is highly diversified by stage, sector and geography. As an experienced partner to outstanding management teams, we help build durable companies with sustainable value. We have raised 19 private equity funds, which have invested more than $81 billion in over 890 companies in more than 40 countries.